Current CDC recommendations mimic guidelines during initial vaccine phases by prioritizing extremely large patient populations for expedited booster vaccinations. We identified every states’ COVID vaccination webpage in February of 2021. Nearly twothirds of states elected not to give adequate vaccination prioritization to patients with cancer during the initial phases under similar guidance, this approach raises the question of whether state-level decisions on how to sub prioritize patients may again inadvertently result in delayed immunizations for particularly vulnerable subgroups – such as patients with cancer. With the delta variant continuing its unchecked global spread and vaccine-related immunity potentially waning, equitable distribution of booster immunizations is essential to minimizing inherent medical, age-related, and socioeconomic inequities in COVID-related morbidity and mortality between populations.
COVID-19 Booster Vaccine Equity for Patients with Cancer